Eight people on the NIH and FDA panel for Covid oversaw the Remdesivir trial got paid directly by Gilead

Eight people on the NIH and FDA panel for Covid oversaw the remdesavir trial got paid directly by Gilead. They changed the endpoint of the study from mortality to a fluffy metric of just recovery time on surviving patients.

Out of thousands of drug trials that I have seen, I have never seen anything like that, especially not with an instant FDA rubber stamp to follow.

Washington Post: Government researchers changed metric to measure coronavirus drug remdesivir during clinical trial https://www.msn.com/en-us/news/us/government-researchers-changed-metric-to-measure-coronavirus-drug-remdesivir-during-clinical-trial/ar-BB13ui2k

This is the panel that oversaw the Remdesivir study:

Be the first to comment

Leave a Reply

Your email address will not be published.


*